Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms-Reference-Cited by-同舟云学术

Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms

Published:2018-01-08 Issue:2 Volume:24 Page:165-175
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Bezzi Marco,Seitzer Nina,Ishikawa Tomoki,Reschke Markus,Chen Ming,Wang Guocan,Mitchell Caitlin,Ng Christopher,Katon Jesse,Lunardi Andrea,Signoretti Sabina,Clohessy John G,Zhang Jiangwen,Pandolfi Pier Paolo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.4463.pdf

Reference62 articles.

1. Egeblad, M., Nakasone, E.S. & Werb, Z. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 18, 884–901 (2010).

2. Hanahan, D. & Coussens, L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309–322 (2012).

3. Quail, D.F. & Joyce, J.A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423–1437 (2013).

4. Nakasone, E.S. et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21, 488–503 (2012).

5. Zou, W., Wolchok, J.D. & Chen, L. PD-L1 (B7–H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci. Transl. Med. 8, 328rv4 (2016).

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSA, an outdated biomarker for prostate cancer: In search of a more specific biomarker, citrate takes the spotlight;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. Characterizing the Tumor Microenvironment and Its Prognostic Impact in Breast Cancer;Cells;2024-09-10

3. Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges;Cancer Letters;2024-09

4. Development of a genome atlas for discriminating benign, preinvasive, and invasive lung nodules;MedComm;2024-07-19

5. p53 at the crossroads of tumor immunity;Nature Cancer;2024-07-15